Both in Biotechnology
Replimune Group vs Vir Biotechnology
Over the past year REPL returned +130.7% and VIR returned +124.2%; their daily moves had a correlation of 0.16.
REPL +130.7% VIR +124.2%Growth of $1, one year, split-adjusted
| Metric | REPL | VIR |
|---|---|---|
| Price | $20.69 | $11.77 |
| Market cap | $1.96B | $1.99B |
| Today | +0.19% | +4.90% |
| 1 month | +56.2% | +1.5% |
| 6 months | +501.5% | +14.4% |
| Year to date | +112.9% | +95.2% |
| 1 year | — | +110.2% |
| Revenue growth (YoY) | — | +19582.5% |
| Gross margin | — | 100.0% |
| Net margin | — | 33.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.6× |
| Net cash | $183.7M | $532.7M |
| Dividend yield | — | — |
| Volatility (60d) | 77.7% | 52.3% |
| Short % of float | 29.6% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).